Efficacy and safety of bepridil for prevention of ICD shocks in patients with Brugada syndrome and idiopathic ventricular fibrillation

Author:

Aizawa Yoshiyasu,Yamakawa Hiroyuki,Takatsuki Seiji,Katsumata Yoshinori,Nishiyama Takahiko,Kimura Takehiro,Nishiyama Nobuhiro,Fukumoto Kotaro,Tanimoto Yoko,Tanimoto Kojiro,Mitamura Hideo,Ogawa Satoshi,Fukuda Keiichi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. Efficacy of quinidine in high-risk patients with Brugada syndrome;Belhassen;Circulation,2004

2. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment;Mizusawa;J Cardiovasc Pharmacol,2006

3. Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide;Sugao;J Cardiovasc Pharmacol,2005

4. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation;Murakami;J Cardiovasc Pharmacol,2010

5. Bepridil up-regulates cardiac Na+channels as a long-term effect by blunting proteasome signals through inhibition of calmodulin activity;Kang;Br J Pharmacol,2009

Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3